MedTrace Logo

Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy

NCT04374188 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2021-03-03

No results posted yet for this study

Summary

Efficacy of ciprofloxacin therapy in avoidance of sepsis in patient undergoing percutanous nephrolithotomy. A randomized controlled trial.

Conditions

  • Nephrolithiasis

Interventions

DRUG

Ciprofloxacin

drug adminstration to ameliorate sepsis incidence

DRUG

Levofloxacin

levofloxacin pill

Sponsors & Collaborators

  • Diaa Eldin Taha Ramadan Mohamed

    lead OTHER

Principal Investigators

  • Diaa Eldin Taha, MD · Lecturer of urology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2021-09-01
Completion
2022-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04374188 on ClinicalTrials.gov